IL17RA | Interleukin 17 receptor A | CD markers Disease related genes Predicted membrane proteins
| | | | | Mixed |
CECR2 | Cat eye syndrome chromosome region, candidate 2 | | | | | | Tissue enhanced |
ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | Plasma proteins Transporters
| | | | | Expressed in all |
BID | BH3 interacting domain death agonist | Mitochondrial proteins
| | | | | Expressed in all |
MICAL3 | Microtubule associated monooxygenase, calponin and LIM domain containing 3 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Expressed in all |
PEX26 | Peroxisomal biogenesis factor 26 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PRODH | Proline dehydrogenase (oxidase) 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enhanced |
DGCR14 | DiGeorge syndrome critical region gene 14 | | | | | | Expressed in all |
HIRA | Histone cell cycle regulator | | | | | | Expressed in all |
MRPL40 | Mitochondrial ribosomal protein L40 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
UFD1L | Ubiquitin fusion degradation 1 like (yeast) | Transporters
| | | | | Expressed in all |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GNB1L | Guanine nucleotide binding protein (G protein), beta polypeptide 1-like | | | | | | Mixed |
TXNRD2 | Thioredoxin reductase 2 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
COMT | Catechol-O-methyltransferase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ARVCF | Armadillo repeat gene deleted in velocardiofacial syndrome | | | | | | Expressed in all |
DGCR8 | DGCR8 microprocessor complex subunit | Plasma proteins
| | | | | Expressed in all |
TRMT2A | TRNA methyltransferase 2 homolog A (S. cerevisiae) | Plasma proteins
| | | | | Expressed in all |
RANBP1 | RAN binding protein 1 | Plasma proteins
| | | | | Expressed in all |
RTN4R | Reticulon 4 receptor | Predicted membrane proteins
| | | | | Tissue enhanced |
GGTLC3 | Gamma-glutamyltransferase light chain 3 | | | | | | Tissue enhanced |
ZNF74 | Zinc finger protein 74 | Transcription factors
| | | | | Mixed |
SCARF2 | Scavenger receptor class F, member 2 | Disease related genes Predicted membrane proteins
| | | | | Mixed |
MED15 | Mediator complex subunit 15 | | | | | | Expressed in all |
SERPIND1 | Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SNAP29 | Synaptosomal-associated protein, 29kDa | Disease related genes
| | | | | Expressed in all |
CRKL | V-crk avian sarcoma virus CT10 oncogene homolog-like | Plasma proteins
| | | | | Expressed in all |
P2RX6 | Purinergic receptor P2X, ligand-gated ion channel, 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
GGT2 | Gamma-glutamyltransferase 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
UBE2L3 | Ubiquitin-conjugating enzyme E2L 3 | Enzymes Plasma proteins
| | | | | Expressed in all |
SDF2L1 | Stromal cell-derived factor 2-like 1 | Predicted secreted proteins
| | | | | Expressed in all |
PPIL2 | Peptidylprolyl isomerase (cyclophilin)-like 2 | Enzymes
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
TOP3B | Topoisomerase (DNA) III beta | Enzymes Plasma proteins
| | | | | Expressed in all |
GGTLC2 | Gamma-glutamyltransferase light chain 2 | | | | | | Tissue enhanced |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
ZNF70 | Zinc finger protein 70 | Transcription factors
| | | | | Mixed |
VPREB3 | Pre-B lymphocyte 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
CHCHD10 | Coiled-coil-helix-coiled-coil-helix domain containing 10 | Mitochondrial proteins
| | | | | Expressed in all |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
SUSD2 | Sushi domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
SNRPD3 | Small nuclear ribonucleoprotein D3 polypeptide 18kDa | Plasma proteins
| | | | | Expressed in all |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SGSM1 | Small G protein signaling modulator 1 | | | | | | Tissue enhanced |
MYO18B | Myosin XVIIIB | | | | | | Group enriched |
TPST2 | Tyrosylprotein sulfotransferase 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CHEK2 | Checkpoint kinase 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
HSCB | HscB mitochondrial iron-sulfur cluster co-chaperone | Mitochondrial proteins
| | | | | Expressed in all |